Navigation Links
Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
Date:6/8/2009

CINCINNATI, June 8 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Jefferies 3rd Annual Healthcare Conference on June 18 as well as the Wachovia Securities 19th Annual Mid-Year Equity Conference on June 24.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

President Simon Higginbotham will participate in the June 18 Jefferies Conference. Chairman and Chief Executive Officer Candace Kendle, PharmD, and Senior Vice President and Chief Financial Officer Keith Cheesman will participate in the June 24 Wachovia Conference.

Jefferies 3rd Annual Healthcare Conference

The Jefferies 3rd Annual Healthcare Conference will be held June 17-18 at the Mandarin Oriental Hotel in New York City. The Kendle presentation by Mr. Higginbotham is scheduled for Thursday, June 18 at 10:45 a.m. Eastern Time.

The presentation will be Webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/jeff35/kndl/. Slides will be available by 8 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

Wachovia Securities 19th Annual Mid-Year Equity Conference

The Wachovia Securities 19th Annual Mid-Year Equity Conference will be held June 23-24 at the Intercontinental Boston Hotel in Boston. The Kendle presentation by Dr. Kendle and Mr. Cheesman is scheduled for Wednesday, June 24 at 3 p.m. Eastern Time.

The presentation will be Webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/wa55/kndl. Slides will be available by 8 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
2. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
3. Kendle Revises Full Year 2008 Guidance
4. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
5. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
6. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
7. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
8. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
9. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
10. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
11. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) is ... at 167 Lynch Creek Way. The Petaluma office features three comfortable patient exam ... rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. Neema ...
(Date:1/20/2017)... ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. ... lift is mounted on wheels, it can be wheeled out of the way and stored ... to the deck. "We have transformed the feedback from customers into specific enhancements and created ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company based in ... children since the holiday season. , β€œIt happens every year around this time,” ... and taking photos, which is the head-to-head gateway that lice need to spread.” , ...
(Date:1/20/2017)... raton florida (PRWEB) , ... January 20, 2017 , ... ... at the Dana Farber Cancer Institute. For Betsy, the clinical trial has been ... her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian cancer ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the ... HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, ... 2013 - 2024" report to their offering. ... The global clinical laboratory testing ... Introduction of innovative solutions on the grounds of maximum efficiency ...
(Date:1/20/2017)... 2017  Palladian Health, a leading provider of ... of an opioid management program which assists physicians ... helps stem the growing tide of dependence on ... chronic non-cancer pain (back pain, neck pain, and ... of evidence regarding long-term effectiveness. The ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
Breaking Medicine Technology: